A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model
Open Access
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 7 (2) , 163-173
- https://doi.org/10.1016/s1525-0016(02)00049-7
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Serum and Ascites Neutralizing Antibodies in Ovarian Cancer Patients Treated with Intraperitoneal Adenoviral Gene TherapyHuman Gene Therapy, 2002
- Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinomaCancer Gene Therapy, 2002
- Adenoviruses in OncologyBioDrugs, 2002
- Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck CancerJournal of Clinical Oncology, 2001
- Update on adenovirus and its vectorsJournal of General Virology, 2000
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- Pre-Existent Adenovirus Antibody Inhibits Systemic Toxicity and Antitumor Activity of CN706 in the Nude Mouse LNCaP Xenograft Model: Implications and Proposals for Human TherapyHuman Gene Therapy, 2000
- Replicative adenoviruses for cancer therapyNature Biotechnology, 2000
- Productive Replication of Human Adenoviruses in Mouse Epidermal CellsJournal of Virology, 2000
- An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinomaThe FASEB Journal, 2000